GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Delta-Fly Pharma Inc (TSE:4598) » Definitions » Research & Development

Delta-Fly Pharma (TSE:4598) Research & Development : 円958.30 Mil (TTM As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Delta-Fly Pharma Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Delta-Fly Pharma's Research & Development for the three months ended in Dec. 2023 was 円284.81 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was 円958.30 Mil.


Delta-Fly Pharma Research & Development Historical Data

The historical data trend for Delta-Fly Pharma's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delta-Fly Pharma Research & Development Chart

Delta-Fly Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Research & Development
Get a 7-Day Free Trial 376.94 1,397.51 866.92 940.79 1,011.83

Delta-Fly Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 335.93 217.30 206.51 249.68 284.81

Delta-Fly Pharma Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円958.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Delta-Fly Pharma  (TSE:4598) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Delta-Fly Pharma Research & Development Related Terms

Thank you for viewing the detailed overview of Delta-Fly Pharma's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Delta-Fly Pharma (TSE:4598) Business Description

Traded in Other Exchanges
N/A
Address
Miyajima Kinno 37-5, Tokushima Prefecture, Kawauchi Town, Tokushima, JPN, 771-0116
Delta-Fly Pharma Inc is a Japan-based company mainly engaged in the discovery and development of gentle anti-cancer agents with module technology.

Delta-Fly Pharma (TSE:4598) Headlines

No Headlines